切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2007, Vol. 01 ›› Issue (05) : 165 -167. doi: 10.3877/cma.j.issn.1674-0807.2007.05.014

实验研究

逆转录病毒介导Dm-dNK 基因在乳腺癌细胞中的表达及细胞杀伤毒性
赵蕾1, 郑新宇2,, 张鸿3, 李继光2, 徐惠绵2   
  1. 1.110001 沈阳,中国医科大学实验技术中心三部
    2.110001 沈阳,第一附属医院乳腺外科
    3.110001 沈阳,基础医学院
  • 收稿日期:2007-04-24 出版日期:2007-10-01
  • 通信作者: 郑新宇
  • 基金资助:
    国家自然科学基金(30371625) 和“863”计划(2006AA02Z493)资助项目

Retrovirus-mediated expression of Dm-dNK in breast cancer cells and its cytotoxicity

Lei ZHAO1, Xin-yu ZHENG,1, Hong ZHANG1, Ji-guang LI1, Hui-mian XU1   

  1. 1.Third Division of Medical Laboratory Technology Center, China Medical University, Shenyang 110000, China
  • Received:2007-04-24 Published:2007-10-01
  • Corresponding author: Xin-yu ZHENG
引用本文:

赵蕾, 郑新宇, 张鸿, 李继光, 徐惠绵. 逆转录病毒介导Dm-dNK 基因在乳腺癌细胞中的表达及细胞杀伤毒性[J/OL]. 中华乳腺病杂志(电子版), 2007, 01(05): 165-167.

Lei ZHAO, Xin-yu ZHENG, Hong ZHANG, Ji-guang LI, Hui-mian XU. Retrovirus-mediated expression of Dm-dNK in breast cancer cells and its cytotoxicity[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2007, 01(05): 165-167.

目的 探讨可否将果蝇多底物脱氧核苷酸激酶(Dm-dNK)表达于乳腺癌细胞,以及其对肿瘤细胞的杀伤效果

方法

构建表达Dm-dNK复制缺陷的逆转录病毒载体;重组病毒感染乳腺癌细胞系MCF7(ER+)及MDA-MB-231(ER-),测定感染细胞酶的活性及对于核苷酸类似物araT 及araC的细胞毒性。

结果

Dm-dNK可以在乳腺肿瘤细胞中表达并具有酶的活性(Western印迹显示细胞内的Dm-dNK蛋白表达);同时,感染的肿瘤细胞对araT及araC的敏感性增加。

结论

Dm-dNK可以定位表达于乳腺肿瘤细胞核并保持酶的活性,Dm-dNK可能成为乳腺肿瘤分子化疗的新方法。

Objective

To evaluate the effects of nucleoside analogphosphorylation by Dm-dNK(Drosophila melanogaster deoxyribonucleosidekinase), and the killing effect as a novel suicide geneon in breast cancer cell lines.

Methods

A replication-deficientretroviral'vector that expresses Dm-dNK was created, and the human breast cancer cells MCF7 (ER + ) and MDA-MB-231 (ER- ) were transduced with the recombinant retrovirus.The enzymatic activity and the sensitivity of the untransfected cells and the cells infected with either GFP (green fluorescent protein) vector alone or the pLE-Dm-dNK-GFP to pyrimidine nucleoside analogs araT(1-β-Darabinofuranosylthymine) and araC (1-β-D-arabinofuranosylcytosine) were determined.

Results

It was showed that the Dm-dNK was enzymatically active and that the over-expression of the enzyme in the tested cell lines resulted in an increased sensitivity to the cytosine nucleoside analogs araT and araC.

Conclusions

Dm-dNK can be locally overexpressed in the nuclei of breast cancer cells and it retains enzymatic activity.It may contribute to the development of novel breast cancer treatment strategies.

[1]
Johansson M, van Rompay A R,Degreve B,et al.Cloning and characterization of the multisubstrate deoxyribonucleoside kinase of Drosophila melanogaster.J Biol Chem,1999,274:23 814 -23 819.
[2]
Zheng X, Johansson M, Karlsson A.Retroviral transduction of cancer cell lines with the gene encoding Drosophila melanogaster multisubstrate deoxyribonucleoside kinase.J Biol Chem, 2000,275:39 125 -39 129.
[3]
Zheng X, Johansson M, Karlsson A.Bystander effects of cancer cell lines transduced with the multisubstrate deoxyribonucleoside kinase of Drosophila melanogaster and synergistic enhancement by hydroxyurea.Mol Pharmacol,2001,60:262 -266.
[4]
Zheng X, Johansson M, Karlsson A.Nucleoside analog cytotoxicityand bystander cell killing of cancer cells expressing Drosophilamelanogaster deoxyribonucleoside kinase in the nucleus or cytosol.Biochem Biophys Res Commun,2001,289:229 -233.
[5]
Hussain R F,Nouri A M,Oliver R T.A new approach for measurementof cytotoxicity using colorimetric assay.J Immunol Methods,1993,160:89 -96.
[6]
Takahashi S, Ito Y, Hatake K,et al.Gene therapy for breast-Cancer:review of clinical gene therapy trials for breast cancer and MDR1 gene therapy trial in Cancer Institute Hospital.Breast Cancer,2006,13:8 -15.
[7]
Springer C J, Niculescu Duvaz I.Prodrug-activating systems in suicide gene therapy.J Clin Invest,2000,105:1161 -1167.
[8]
Freeman S M, Abboud C N, Whartenby K A, et al .The “bystandereffect”:tumor regression when a fraction of the tumor mass isgenetically modified.Cancer Res,1993,53:5274 -5283.
[9]
Mesnil M, Piccoli C, Tiraby G, et al.Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins.Proc Natl Acad Sci USA,1996,93:31 831 - 31 835.
[10]
Moolten F L.Tumor çhemosensitivity conferred by insertedherpes thymidine kinase genes:paradigm for a prospective cancercontrol strategy.Cancer Res,1986,46:5276 -5281.
[11]
Ayala G,Satoh T, Li R,et al.Biological response determinants in HSV-tk + ganciclovir gene therapy for prostate cancer.Mol Ther,2006,13:716 -728.
[12]
Pandha H S, Martin L A, Rigg A, et al .Genetic prodrug activation therapy for breast cancer:a phase I clinical trial of erbB-2-directed suicide gene expression.JClin Oncol, 1999, 17:2180 - 2189.
[13]
Braybrooke J P, Slade A, Deplanque G,et al .Phase I study of MetXia-P450 gene therapy and oral cyclophosphamide forpatients with advanced breast cancer or melanoma.Clin Cancer Res,2005,11:1512 -1520.
[1] 钟琰, 吴爱国, 纪术峰, 沈三弟. 短发夹RNA 沉默促肝细胞再生磷酸酶-3 基因表达对乳腺癌MCF-7 细胞生长和侵袭能力的影响[J/OL]. 中华乳腺病杂志(电子版), 2011, 05(03): 313-322.
[2] 王佳妮, 刘仁斌, 李俊杰, Mohamed Abdalwali·Thabit, Samuel D.Rabkin. 转基因溶瘤性单纯疱疹病毒对人类乳腺癌的治疗作用[J/OL]. 中华乳腺病杂志(电子版), 2009, 03(06): 642-650.
[3] 吴爱国. 乳腺癌基因治疗研究现状[J/OL]. 中华乳腺病杂志(电子版), 2008, 02(05): 35-40.
[4] 刘晶晶, 张瑾. P27 的生物学功能及其在乳腺癌中的研究进展[J/OL]. 中华乳腺病杂志(电子版), 2008, 02(03): 30-33.
[5] 孙玉兰, 王亚红, 张媛媛, 许少峰, 付丽. 突变p53 基因的反义拯救研究[J/OL]. 中华乳腺病杂志(电子版), 2008, 02(01): 40-43.
[6] 葛盈盈, 岳金, 薛令法, 许尧祥, 赵浩然, 崔明雪, 肖文林. 靶向p38丝裂素活化蛋白激酶对兔唇裂术后瘢痕增生的影响[J/OL]. 中华口腔医学研究杂志(电子版), 2023, 17(01): 37-44.
[7] 周华平, 彭和平, 刘启才. 腺病毒介导NK4基因和单核细胞趋化蛋白1基因共表达对胰腺癌细胞的影响[J/OL]. 中华普通外科学文献(电子版), 2013, 07(03): 165-169.
[8] 刘恒, 侯宇川. 膀胱癌新型灌注药物的研究进展[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 445-451.
[9] 张一健, 赵龙, 杨扬, 张贝贝, 张译予, 张斌. 造血干/祖细胞体外扩增和临床应用[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(02): 122-127.
[10] 孙秀丽, 刘振宇, 唐婷婷, 张景尚, 李猛, 毛迎燕, 万修华. 关注后发性白内障的发病机制及防控措施[J/OL]. 中华眼科医学杂志(电子版), 2023, 13(04): 193-198.
[11] 陈圣攀, 左晓坤, 夏鹰. 脑胶质瘤的治疗进展[J/OL]. 中华神经创伤外科电子杂志, 2017, 03(02): 105-108.
[12] 何天齐, 张晓韬, 王敏, 李秀华. 腺相关病毒在帕金森病研究中的应用进展[J/OL]. 中华临床医师杂志(电子版), 2020, 14(08): 643-647.
[13] 尹志强, 邢万红, 马捷, 杨建新. 基因转导技术治疗心力衰竭的研究进展[J/OL]. 中华临床医师杂志(电子版), 2018, 12(03): 160-163.
[14] 王存川, 董志勇. 精准肥胖外科[J/OL]. 中华肥胖与代谢病电子杂志, 2016, 02(01): 1-6.
阅读次数
全文


摘要